TNXP - Tonix Pharmaceuticals Holding Corp - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TNXP is currently covered by 1 analysts with an average price target of $-4742.98. This is a potential upside of $-4759.86 (-28198.22%) from yesterday's end of day stock price of $16.88.

Tonix Pharmaceuticals Holding Corp's activity chart (see below) currently has 0 price targets and 5 ratings on display. The stock rating distribution of TNXP is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50.79% with an average time for these price targets to be met of 71.33 days.

Highest price target for TNXP is $70, Lowest price target is $70, average price target is $70.

Most recent stock forecast was given by ROBERT LEBOYER from NOBLE CAPITAL on 20-Mar-2025. First documented stock forecast 26-Jun-2017.

Best performing analysts who are covering TNXP - Tonix Pharmaceuticals Holding Corp:

Scott Henry Jim Molloy Robert Leboyer

Currently out of the existing stock ratings of TNXP, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$70

$53.12 (314.69%)

23 days ago
(20-Mar-2025)

0/1 (0%)

$51.81 (284.83%)

Buy

$6.5

1 years 8 months 11 days ago
(01-Aug-2023)

6/7 (85.71%)

$4.62 (245.74%)

153

Buy

$13312

$13300.05 (111297.49%)

5 years 7 months 13 days ago
(30-Aug-2019)

2/3 (66.67%)

$-14336 (-51.85%)

61

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TNXP (Tonix Pharmaceuticals Holding Corp) average time for price targets to be met?

On average it took 71.33 days on average for the stock forecasts to be realized with a an average price target met ratio 50.79

Which analyst has the current highest performing score on TNXP (Tonix Pharmaceuticals Holding Corp) with a proven track record?

SCOTT HENRY

Which analyst has the current lower performing score on TNXP (Tonix Pharmaceuticals Holding Corp) with a proven track record?

ROBERT LEBOYER

Which analyst has the most public recommendations on TNXP (Tonix Pharmaceuticals Holding Corp)?

Scott Henry works at ALLIANCE GLOBAL PARTNERS and has 7 price targets and 4 ratings on TNXP

Which analyst is the currently most bullish on TNXP (Tonix Pharmaceuticals Holding Corp)?

Scott Henry with highest potential upside - $13300.05

Which analyst is the currently most reserved on TNXP (Tonix Pharmaceuticals Holding Corp)?

Jim Molloy with lowest potential downside - -$0

Tonix Pharmaceuticals Holding Corp in the News

Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix’s Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana’s Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies

Agreement includes the use of Tonix’s TNX-1500, as part of an immunomodulatory regimen to reduce rejection of Makana’s genetically engineered pig organs in xenotransplantation Establishes framework for Makana’s kidney, heart and islet cell programs to utilize TNX-1500 for preclinical studies in support of regulatory filings for potential use in human recipients CHATHAM, N.J. and MIAMI,...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?